In silico identification and ex vivo evaluation of Toxoplasma gondii peptides restricted to HLA-A*02, HLA-A*24 and HLA-B*35 alleles in human PBMC from a Colombian population.

MLA

Vargas-Montes, Mónica, et al. “In Silico Identification and Ex Vivo Evaluation of Toxoplasma Gondii Peptides Restricted to HLA-A*02, HLA-A*24 and HLA-B*35 Alleles in Human PBMC from a Colombian Population.” Medical Microbiology and Immunology, vol. 214, no. 1, Dec. 2024, p. 5. EBSCOhost, https://doi.org/10.1007/s00430-024-00815-x.

APA

Vargas-Montes, M., Valencia-Jaramillo, M. C., Valencia-Hernández, J. D., Gómez-Marín, J. E., Arenas, A. F., & Cardona, N. (2024). In silico identification and ex vivo evaluation of Toxoplasma gondii peptides restricted to HLA-A*02, HLA-A*24 and HLA-B*35 alleles in human PBMC from a Colombian population. Medical Microbiology and Immunology, 214(1), 5. https://doi.org/10.1007/s00430-024-00815-x

Chicago

Vargas-Montes, Mónica, María Camila Valencia-Jaramillo, Juan David Valencia-Hernández, Jorge Enrique Gómez-Marín, Ailan Farid Arenas, and Néstor Cardona. 2024. “In Silico Identification and Ex Vivo Evaluation of Toxoplasma Gondii Peptides Restricted to HLA-A*02, HLA-A*24 and HLA-B*35 Alleles in Human PBMC from a Colombian Population.” Medical Microbiology and Immunology 214 (1): 5. doi:10.1007/s00430-024-00815-x.